Come Chill at Dexcom’s ‘No Pricks Parlour’ With Ed Gamble for Diabetes Awareness Week, Celebrating You!
June 13 2022 - 4:00AM
Business Wire
- This year’s Diabetes Awareness Week (13-19 June) is celebrating
the triumphs and challenges for all people with diabetes.
- To celebrate the week, as well as the updated NICE (National
Institute of Health and Care Excellence) guidelines, which will
allow more people than ever before have access to modern diabetes
management technology, Dexcom is hosting its ‘No Pricks Parlour’ in
London on 14 June.
- Dexcom will soon be expanding its range of real-time continuous
glucose monitoring (rt-CGM) systems to include Dexcom ONE and
Dexcom G7 Continuous Glucose Monitoring (CGM) System, promoting
wider access to diabetes technology.
Come chill with us! This week is Diabetes Awareness Week and
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time
continuous glucose monitoring (rt-CGM) for people with diabetes, is
honouring the theme of ‘celebrating you’ with its ‘No Pricks
Parlour’, a pop-up ice cream van at London’s South Bank. Open
tomorrow, Tuesday 14 June, for one day only, everyone is invited to
enjoy free ice cream along with the opportunity to learn about the
importance of access to finger prick-free† CGM. There’s even the
chance to meet Comedian and Dexcom Warrior Ed Gamble, who will be
stopping by to share his diabetes journey and celebrate new
innovations in diabetes technology.
“Even as a comedian, I can safely say no one likes a prick,”
says Dexcom Warrior and No Pricks Parlour special guest Ed
Gamble. “I was diagnosed with Type 1 diabetes age 13, and I
used to prick my finger several times a day to stay on top of my
glucose levels. Since using Dexcom CGM, taking care of my diabetes
has been easier and given me more time for the things I love to do.
Greater access to diabetes management tools – like Dexcom’s CGM -
is so cool, because even more people will be able to use this
life-changing technology. Now that is bloody great news, and I’m
ready for an ice cream to celebrate!”
Dexcom’s No Pricks Parlour
In a bid to celebrate those with diabetes, ‘good vibes only’ and
‘no pricks allowed’, No Pricks Parlour visitors will be offered a
delicious cactus-style ice cream (made without pricks, of course).
While guests sit back, relax and enjoy Dexcom’s “Prickin’
Delicious” ice cream, a delicious green cactus flavour made
with aloe and notes of orange, they’ll have the opportunity to
learn about the benefits of CGM. There’s also the chance to see
more famous faces, as other Dexcom Warriors will be stopping by to
join the celebrations and share their diabetes stories!
Details on the No Pricks Parlour below:
- Where: The Queen’s Walk, London South Bank
- Day: Tuesday 14th June - one day only!
- Time: 11:00 a.m. to 6:00 p.m. BST
- Why: To kick off Diabetes Awareness Week, Dexcom is
celebrating all people with diabetes and improved access to CGM by
offering complimentary prick-free cactus-style ice cream for all.
With Dexcom CGM, there are zero finger pricks† for diabetes
management!
On average, people living with diabetes who don’t have access to
CGM prick their fingers up to 10 times daily to measure their
glucose levels. That’s generating nearly 10 litres of blood a day
across all people with diabetes1. However with Dexcom CGM, people
with Type 1 diabetes can know with a quick glance of their
smartphone or watch* their glucose number and where it’s headed –
all with zero finger pricks† or scanning.
Now, more people than ever before will have access to this
crucial technology. NICE recently updated their guidelines to
recommend all people with Type 1 diabetes be offered a choice of
glucose sensors, such as rt-CGM. This means people with diabetes
can say goodbye to routine painful finger pricks†, and take back
the moments many take for granted – like having an ice cream cone
without wondering how it will affect glucose levels.
Dexcom’s Expanded Product Range
There’s even more reason to celebrate wider access to finger
prick-free† CGM at the No Pricks Parlour. Dexcom will soon be
adding two new products to its range to include Dexcom ONE and
Dexcom G7. Dexcom ONE is currently in review to be added to the NHS
England Drug Tariff and is available now to purchase via
Dexcom.com, and the Dexcom G7 is a revolutionary CGM with CE Mark#
in Europe, which will launch later this year. The products
represent the best in rt-CGM and will give greater choice and
access to modern diabetes management technology for everyone with
diabetes in the UK.
Dexcom CGM systems give users a fuller picture of their glucose
numbers and trends to help better manage diabetes, so they can live
healthier, more confident lives. Across the range, users can
expect:
- Real-time glucose readings without finger pricks† or
scanning.
- Exceptional accuracy§ and better-informed treatment
decisions‡.
- Intuitive features and customisable alerts.
- Proven results – lower HbA1c level and spend more time in range
– the percentage of time spent with glucose levels in a healthy
range2, 3.
“At Dexcom, it’s our number one priority to provide people with
diabetes the most modern, innovative technology that allows them
greater control and improved health outcomes,” says Karen
Baxter, Vice President, UK & Ireland, Benelux, France and Spain
at Dexcom. “With Dexcom ONE currently in review to be added to
NHS Drug Tariffs across UK regions and the Dexcom G7 as the most
advanced CGM on the market, our expanded product range will help to
do just that. We can’t wait to bring this innovation to the UK
market and look forward to celebrating Diabetes Awareness week and
sharing more over the coming months.”
At launch, the Dexcom G7 and Dexcom ONE will join the Dexcom G6
CGM System to mark the most exciting and important milestone in
diabetes management technology to date, paving the way for greater
choice and access to real-time CGM. To find out more, visit
https://www.dexcom.com/en-GB.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, and with operations across
Europe, Dexcom has emerged as a leader of diabetes care technology.
By listening to the needs of users, caregivers, and providers,
Dexcom simplifies and improves diabetes management around the
world. For more information about Dexcom CGM, visit
https://www.dexcom.com/en-GB.
________________________________________________________________________________
† If your glucose alerts and readings from the Dexcom CGM do not
match symptoms or expectations, use a blood glucose meter to make
diabetes treatment decisions.
*For a list of compatible devices, visit
www.dexcom.com/en-GB/compatibility
#CE2797
‡Discuss with your HCP on how to use CGM information to manage
diabetes. §Dexcom G6 and Dexcom ONE User Guides. To obtain the
Instructions for use for these products, click here. Note that
labelling may differ in different countries. 1 J Diabetes Sci
Technol. 2014 Jul; 8(4): 691–698. “A Clinical Evaluation of Routine
Blood Sampling Practices in Patients With Diabetes: Impact on
Fingerstick Blood Volume and Pain”.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764211/ 2 Beck RW, et
al. JAMA. 2017;317(4):371-378. 3 Soupal J. et al. Diabetes Care
2019:43(1):37-43 © 2022 Dexcom, Inc. Dexcom, Dexcom ONE, Dexcom G6
and Dexcom G7 are registered trademarks of DexCom, Inc. in the
U.S., and may be registered in other countries. All rights
reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220613005072/en/
Allison+Partners for Dexcom dexcomUK@allisonpr.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jul 2024 to Aug 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Aug 2023 to Aug 2024